910377-29-6

Upstream product

• 26734-08-7 4-amino-2-methyl-2-butanol 
• 1493-27-2 ortho-nitrofluorobenzene 

Downstream Products

• 910377-38-7 N-{1,1-dimethyl-3-[(2-nitrophenyl)amino]propyl}formamide 
• 910377-30-9 4-[(2-aminophenyl)amino]-2-methyl-2-butanol 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME

The present specification provides a heterocyclic compound and an organic light emitting device using the same. The organic light emitting device comprises: a first electrode; a second electrode facing the first electrode; and one or more organic material layers including a light emitting layer formed between the first electrode and the second electrode, wherein the organic material layers comprise the heterocyclic compound.COPYRIGHT KIPO 2015

Copper-catalyzed benzylic C(sp3)-H alkoxylation of heterocyclic compounds

We achieved intra- and intermolecular C(sp3)-H alkoxylation of benzylic positions of heteroaromatic compounds using CuBrn (n = 1, 2)/5,6-dimethylphenanthroline (or 4,7-dimethoxyphenanthroline) and ( tBuO)2 as a

Copper-catalyzed C-H alkoxylation of azoles

We achieved copper-catalyzed intramolecular and intermolecular alkoxylation of azoles. This reaction is a rare example of transition-metal-catalyzed C-H alkoxylation of heteroaromatic compounds. In addition, the alkoxylation reaction proceeded well even i

BENZIMIDAZOLONE DERIVATIVES

This invention relates to compounds and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a therapeutically effective am

BENZIMIDAZOLONE DERIVATIVES AS CB2 RECEPTOR LIGANDS

This invention relates to compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein: A, B, R1, R2 and R3 are each as described herein, and compositions containing such compounds and the use of suc